Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabizon

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Pharmaceutical Research|July 9, 1999
Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomesS Bandak, A Ramu, Y Barenholz, et al.
Anti-Cancer Drugs|November 22, 2014
Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomesEsther Tahover, Yogita P Patil, Alberto A Gabizon
Biochimica Et Biophysica Acta|August 24, 1992
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseA T Horowitz, Y Barenholz, A A Gabizon
Anti-Cancer Drugs|May 2, 2000
Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancerA Hubert, O Lyass, D Pode, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Development of liposomal anthracyclines: from basics to clinical applicationsA Gabizon, D Goren, R Cohen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2016
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapyAlberto A Gabizon, Yogita Patil, Ninh M La-Beck
International Journal of Cancer|March 3, 1995
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignanciesA M Vexler, X Mou, A A Gabizon, et al.
British Journal of Cancer|May 1, 1985
Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour modelA Gabizon, D Goren, Z Fuks, et al.
Anti-Cancer Drugs|October 4, 2014
Pharmacokinetics of low molecular weight heparin in patients with malignant tumorsNicola J Nasser, Mira Na'amad, Ido Weinberg, et al.
Cancer Investigation|December 8, 2004
Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignanciesAlberto A Gabizon, Olga Lyass, Gerald J Berry, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Pharmaceutical Research|July 9, 1999
Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomesS Bandak, A Ramu, Y Barenholz, et al.
Anti-Cancer Drugs|November 22, 2014
Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomesEsther Tahover, Yogita P Patil, Alberto A Gabizon
Biochimica Et Biophysica Acta|August 24, 1992
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseA T Horowitz, Y Barenholz, A A Gabizon
Anti-Cancer Drugs|May 2, 2000
Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancerA Hubert, O Lyass, D Pode, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 1998
Development of liposomal anthracyclines: from basics to clinical applicationsA Gabizon, D Goren, R Cohen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2016
New insights and evolving role of pegylated liposomal doxorubicin in cancer therapyAlberto A Gabizon, Yogita Patil, Ninh M La-Beck
International Journal of Cancer|March 3, 1995
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignanciesA M Vexler, X Mou, A A Gabizon, et al.
British Journal of Cancer|May 1, 1985
Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour modelA Gabizon, D Goren, Z Fuks, et al.
Anti-Cancer Drugs|October 4, 2014
Pharmacokinetics of low molecular weight heparin in patients with malignant tumorsNicola J Nasser, Mira Na'amad, Ido Weinberg, et al.
Cancer Investigation|December 8, 2004
Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignanciesAlberto A Gabizon, Olga Lyass, Gerald J Berry, et al.
Pageof 9